MARC details
000 -LEADER |
fixed length control field |
02305nam a22003015i 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
EG-CaNGU |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20240218133654.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
231102t2017 enka fr 001 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780857113207 |
040 ## - CATALOGING SOURCE |
Transcribing agency |
EG-CaNGU |
Original cataloging agency |
EG-CaNGU |
Language of cataloging |
eng |
Modifying agency |
EG-CaNGU |
Description conventions |
rda |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.1341 |
Item number |
BNF |
Edition number |
23 |
130 0# - MAIN ENTRY--UNIFORM TITLE |
Uniform title |
British National Formulary. |
Number of part/section of a work |
74. |
Date of a work |
September 2017 - March 2018. |
9 (RLIN) |
1081 |
245 10 - TITLE STATEMENT |
Title |
BNF. |
Number of part/section of a work |
74 : |
Remainder of title |
September 2017 - March 2018 / |
246 33 - VARYING FORM OF TITLE |
Title proper/short title |
British National Formulary. |
Number of part/section of a work |
74 |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
London, England : |
Name of producer, publisher, distributor, manufacturer |
BMJ Group, |
-- |
Pharmaceutical Press, |
Date of production, publication, distribution, manufacture, or copyright notice |
[2017] |
264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Date of production, publication, distribution, manufacture, or copyright notice |
©2017 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xx, 1527 pages : |
Other physical details |
illustrations ; |
Dimensions |
21 cm |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
unmediated |
Media type code |
n |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
volume |
Carrier type code |
nc |
Source |
rdacarrier |
500 ## - GENERAL NOTE |
General note |
Includes index. |
505 00 - FORMATTED CONTENTS NOTE |
Formatted contents note |
Preface -- Acknowledgements -- How BNF publications are constructed -- How to use BNF Publications in print -- Changes -- Guidance on Prescribing -- Prescription writing -- Emergency supply of medicines -- Controlled drugs and drug dependence -- Adverse reactions to drugs -- Guidance on intravenous infusions -- Prescribing for children -- Prescribing in hepatic impairment -- Prescribing in renal impairment -- Prescribing in pregnancy -- Prescribing in breast-feeding -- Prescribing in palliative care -- Prescribing for the elderly -- Drugs and sport -- Prescribing in dental practice -- Gastro-intestinal system -- Cardiovascular system -- Respiratory system -- Nervous system -- Infection -- Endocrine system -- Genito-urinary system -- Immune system and malignant disease -- Blood and nutrition -- Musculoskeletal system -- Eye -- Ear, nose and oropharynx -- Skin -- Vaccines -- Anaesthesia -- Emergency treatment of poisoning -- Dental Practitioners' Formulary -- Nurse Prescribers' Formulary -- Non-medical prescribing -- Index of proprietary manufacturers -- Special-order Manufacturers -- Index -- Medical emergencies in the community. |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pharmacopoeias |
Geographic subdivision |
Great Britain. |
Source of heading or term |
NGU-sh |
9 (RLIN) |
2575 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Emergency medicine. |
Source of heading or term |
NGU-sh |
9 (RLIN) |
227 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Medicine. |
Source of heading or term |
NGU-sh |
9 (RLIN) |
1456 |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
British Medical Association, |
Relator term |
author. |
9 (RLIN) |
1086 |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
Royal Pharmaceutical Society of Great Britain, |
Relator term |
author. |
9 (RLIN) |
1088 |